Upsher-Smith Laboratories, Inc. has announced the U.S. launch of Clomipramine Hydrochloride Capsules* USP, 25 mg, 50 mg and 75 mg, the generic equivalent to Mallinckrodt Pharmaceuticals' Anafranil® (clomipramine hydrochloride) Capsules USP.
The clomipramine hydrochloride capsules market had U.S. sales of approximately $172 million for the 12 months ending December 2016, according to IMS Health.
"Upsher-Smith has long been recognized within the pharmaceutical industry as a trusted name in generics," said Rusty Field, President, Upsher-Smith. "This is an exciting time for the Company. Upsher-Smith currently has more active ANDA programs in development than at any point in its history and is committed to expanding its portfolio of quality, high-value generic products through both internal development and strategic partnerships."
Product Information
|
Product
|
Strength
|
NDC/List #
|
Size
|
|
Clomipramine Hydrochloride Capsules
|
25 mg
|
0832-0630-11
|
100-count bottle
|
|
Clomipramine Hydrochloride Capsules
|
50 mg
|
0832-0631-11
|
100-count bottle
|
|
Clomipramine Hydrochloride Capsules
|
75 mg
|
0832-0632-11
|
100-count bottle
|
|
*Clomipramine (P-XPD-1342640) is a product of Sandoz Inc., 100 College Road West, Princeton NJ 08540 (P-XPD-1342640)
|